Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 153 | 253 | 813 | 883 | 133 |
| Receivables | 129 | 146 | 373 | 1,201 | 1,257 |
| TOTAL | $384 | $539 | $1,363 | $2,166 | $1,479 |
| Non-Current Assets | |||||
| PPE Net | 9 | 9 | 11 | 14 | 16 |
| TOTAL | $9 | $9 | $11 | $14 | $16 |
| Total Assets | $393 | $548 | $1,374 | $2,180 | $1,495 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,409 | 8,430 | 8,422 | 8,307 | 7,480 |
| Accounts payable and accrued liabilities | 3,190 | 2,993 | 3,009 | 2,951 | 3,167 |
| TOTAL | $11,617 | $11,434 | $11,442 | $11,279 | $10,648 |
| Non-Current Liabilities | |||||
| Long Term Debt | 529 | 442 | 508 | 529 | 580 |
| TOTAL | $529 | $442 | $508 | $529 | $580 |
| Total Liabilities | $12,146 | $11,876 | $11,950 | $11,808 | $11,228 |
| Shareholders' Equity | |||||
| Common Shares | 30,476 | 30,723 | 30,600 | 30,418 | 30,227 |
| Retained earnings | -53,733 | -53,685 | -52,755 | -51,544 | -51,384 |
| Other shareholders' equity | 447 | 410 | 852 | 847 | 842 |
| TOTAL | $-11,753 | $-11,329 | $-10,577 | $-9,629 | $-9,732 |
| Total Liabilities And Equity | $393 | $548 | $1,374 | $2,180 | $1,495 |